
High-end Ophthalmic Medical Device Developer
TowardPi's self-developed and self-manufactured high-end medical equipment, such as ophthalmic OCT, has gained a solid foothold in the Chinese market due to its significantly leading technological advantages, consistently ranking among the top in annual sales volume and price for three consecutive years. In the second half of 2024, TowardPi officially entered the overseas market, starting to receive international orders after obtaining the EU CE MDR certification in July, with batch shipments commencing from September.
Despite significantly outperforming international well-known brands in performance metrics, TowardPi is also one of the rare Chinese medical equipment manufacturers whose prices are notably higher than imported brands in China.The entry-level model Yaoguang is already priced higher than the flagship models of most brands in the European and American markets, while the price of TowardPi's own flagship model, Beiming, is even several times higher. Will overseas ophthalmology users, who have long been accustomed to using high-end medical brands from Europe, America, and Japan, be willing to pay such a high premium for this new brand from China? Let’s take a look at TowardPi Medical's overseas performance in such a short time.
High prices are no barrier to overseas users' pursuit of ultimate performance. TowardPi Medical OphthalmologyOCT Products Shipped to Europe, Asia, and the Americas. As of December 2024, Cumulative Orders Exceed 60 Units with Most Delivered. Various Informal Orders (Research Cooperation, Leasing, Deferred Payment, Donations, Temporary Display, etc.)Not included in overseas statistics。This figure has already surpassed the level of the same period in the year when TowardPi was first listed in China, and it shows a strong growth momentum.

— Scan the QR code to follow us —


WeChat Official Account
WeChat Video Channel

Every like and view you give, I sincerely take as a sign of affection.